Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP480236.RAducyoUIGdIVaVvGpUKXuXhimdnHlwhCk-J9Yz9qF4Ak130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP480236.RAducyoUIGdIVaVvGpUKXuXhimdnHlwhCk-J9Yz9qF4Ak130_assertion type Assertion NP480236.RAducyoUIGdIVaVvGpUKXuXhimdnHlwhCk-J9Yz9qF4Ak130_head.
- NP480236.RAducyoUIGdIVaVvGpUKXuXhimdnHlwhCk-J9Yz9qF4Ak130_assertion description "[Assuming haematogenous prostate tissue-specific mRNA species to be representative for the presence of circulating prostate cancer cells, an impressive series of clinical studies, for the greater part addressing mRNA encoding for prostate-specific antigen (PSA), were performed to improve pre-operative staging (molecular staging) and prognosis of prostate cancer, and to study iatrogenic cell dissemination.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP480236.RAducyoUIGdIVaVvGpUKXuXhimdnHlwhCk-J9Yz9qF4Ak130_provenance.
- NP480236.RAducyoUIGdIVaVvGpUKXuXhimdnHlwhCk-J9Yz9qF4Ak130_assertion evidence source_evidence_literature NP480236.RAducyoUIGdIVaVvGpUKXuXhimdnHlwhCk-J9Yz9qF4Ak130_provenance.
- NP480236.RAducyoUIGdIVaVvGpUKXuXhimdnHlwhCk-J9Yz9qF4Ak130_assertion SIO_000772 15703810 NP480236.RAducyoUIGdIVaVvGpUKXuXhimdnHlwhCk-J9Yz9qF4Ak130_provenance.
- NP480236.RAducyoUIGdIVaVvGpUKXuXhimdnHlwhCk-J9Yz9qF4Ak130_assertion wasDerivedFrom befree-2016 NP480236.RAducyoUIGdIVaVvGpUKXuXhimdnHlwhCk-J9Yz9qF4Ak130_provenance.
- NP480236.RAducyoUIGdIVaVvGpUKXuXhimdnHlwhCk-J9Yz9qF4Ak130_assertion wasGeneratedBy ECO_0000203 NP480236.RAducyoUIGdIVaVvGpUKXuXhimdnHlwhCk-J9Yz9qF4Ak130_provenance.